HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19

INTRO: The concept of training immunity originally developed for other diseases has gained attraction during the epidemic. Several clinical trials and epidemiological analyses of populations previously immunized with BCG and other vaccines were the focus of scientific discussions. Here we show the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillen, G., Limonta, M., Muzio, V., Cinza, Z., Lemos, G., Chinea, G., Martin, A., Gonzalez-Roche, D., Valdes, I., Mendosa, Y., Aguiar, J., Bequet, M., Marques, G., Zamora, J., Penton, E., Iglesias, E., Aguilar, J., Cruz, O., Ayala, M., Pimentel, E., Martinez, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Oral Session 3: Vaccines DevelopmentsDate: Saturday, Nov 19, 2022 Time: 8:00-9:00Venue: Banquet Hall
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186936/
http://dx.doi.org/10.1016/j.ijid.2023.04.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186936/
http://dx.doi.org/10.1016/j.ijid.2023.04.029

Ejemplares similares